| 4700 |
Centers for Disease Control and Prevention |
Html |
en |
Evaluating a preventive services index to adjust for healthy behaviors in observational studies of older adults |
null |
| preventive therapy | 0.294763 |
| fitness program | 0.295065 |
| earlier clinical preventive | 0.317603 |
| Silver Sneakers | 0.320965 |
| observational studies | 0.33945 |
| administrative data | 0.264127 |
| preventive office visit | 0.367332 |
| original preventive services | 0.388522 |
| preventive visit | 0.291066 |
| alternative index | 0.315681 |
| pneumococcal vaccination | 0.374046 |
| health care costs | 0.321116 |
| preventive variables | 0.322097 |
| preventive behavior | 0.281634 |
| alternative preventive indexes | 0.301914 |
| PSA test | 0.276362 |
| preventive services index | 0.902282 |
| index date | 0.417516 |
| fecal occult blood | 0.379799 |
| original index | 0.276792 |
| occult blood test | 0.309748 |
| administrative database | 0.310922 |
| influenza vaccination | 0.419063 |
| colon cancer screening | 0.318381 |
| Group Health Cooperative | 0.260983 |
|
| physical activity program | 0.289075 |
| alternative preventive services | 0.431306 |
| preventive medical services | 0.331519 |
| principal components analysis | 0.425073 |
| flexible sigmoidoscopy | 0.309014 |
| preventive care office | 0.339175 |
| preventive procedures | 0.285782 |
| physical activity benefit | 0.278466 |
| clinical preventive services | 0.364174 |
| health care | 0.333539 |
| health maintenance organization | 0.294793 |
| preventive measures | 0.283636 |
| preventive health care | 0.30322 |
| preventive office visits | 0.315393 |
| colon cancer | 0.376006 |
| preventive behaviors | 0.306586 |
| preventive services indexes | 0.373591 |
| people | 0.261348 |
| prostate cancer screening | 0.353753 |
| physical activity | 0.300447 |
| selection bias | 0.424956 |
| prostate cancer | 0.355309 |
| preventive visits | 0.320478 |
| principal component analysis | 0.35258 |
|
CLICK HERE |
| 4851 |
Centers for Disease Control and Prevention |
Html |
en |
Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests |
For clinicians about the the advantages and disadvantages of rapid influenza diagnostic tests RIDTs, their use in clinical decision-making and how to interpret results - CDC |
| influenza | 0.981756 |
| Avian Influenza | 0.501445 |
| novel influenza | 0.59776 |
| Weekly U.S. Influenza | 0.552502 |
| accurate influenza testing | 0.535218 |
| influenza virus detection | 0.572942 |
| influenza virus vaccine | 0.562113 |
| influenza outbreaks | 0.599421 |
| Rapid Influenza Diagnostic | 0.559891 |
| laboratory-confirmed influenza diagnosis | 0.517842 |
| intranasal influenza vaccination | 0.505782 |
| U.S. Influenza Surveillance | 0.550126 |
| positive influenza testing | 0.536925 |
| live attenuated influenza | 0.555686 |
| community influenza activity | 0.527863 |
| low influenza activity | 0.559263 |
| influenza virus infection | 0.807876 |
| influenza molecular assays | 0.514426 |
| Influenza Surveillance Report | 0.550116 |
| Influenza Virus Testing | 0.589282 |
| variant influenza | 0.520217 |
| influenza A virus | 0.5984 |
| influenza season | 0.561135 |
|
| viable influenza virus | 0.550664 |
| influenza activity | 0.764995 |
| influenza virus strains | 0.536918 |
| seasonal influenza | 0.600918 |
| new generation influenza | 0.506503 |
| influenza seasonal activity | 0.513353 |
| current influenza activity | 0.524215 |
| nosocomial influenza outbreaks | 0.512488 |
| specific influenza | 0.497129 |
| rapid influenza tests | 0.507715 |
| influenza testing | 0.65969 |
| influenza viral antigen | 0.576872 |
| influenza viruses | 0.568461 |
| live influenza virus | 0.549066 |
| influenza increases | 0.514775 |
| influenza virus | 0.866445 |
| rapid influenza | 0.592167 |
| peak influenza activity | 0.59203 |
| influenza testing results | 0.573343 |
| influenza vaccine virus | 0.530046 |
| novel swine-origin influenza | 0.501108 |
| influenza  prevalence | 0.508611 |
| influenza diagnostic tests | 0.665876 |
|
CLICK HERE |
| 5720 |
Centers for Disease Control and Prevention |
Html |
en |
Furfural - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6266 |
Centers for Disease Control and Prevention |
Html |
en |
Lung cancer rates decline nationwide - Press Release: September 15, 2011 |
Lung cancer rates decline nationwide |
| National Cancer Institute′s | 0.48531 |
| CDC′s Morbidity | 0.437806 |
| lung cancer | 0.994136 |
| CDC′s cancer prevention | 0.483264 |
| Disease Control | 0.446611 |
| visit www.cdc.gov/cancer | 0.436567 |
| larger reductions | 0.440697 |
| commonly diagnosed cancer | 0.486185 |
| percent smoke-free policies | 0.475691 |
| lung cancers | 0.512707 |
| smoking behavior | 0.450587 |
| lung cancer cases | 0.644362 |
| smoking–related health care | 0.474309 |
| free resources | 0.436114 |
| Columbia | 0.41257 |
| lung cancer data | 0.556586 |
| Cancer Registries | 0.45429 |
| Factor Surveillance | 0.435697 |
| tobacco control efforts | 0.531 |
| HUMAN SERVICES | 0.435873 |
| District | 0.412577 |
| Study findings | 0.437312 |
| women | 0.459658 |
| visit www.cdc.gov/tobacco | 0.436467 |
| smoking prevalence | 0.455776 |
|
| End Results Program | 0.470025 |
| United States | 0.516525 |
| cause | 0.411966 |
| control program | 0.438019 |
| lung cancer rates | 0.806068 |
| CDC′s National Program | 0.471103 |
| men | 0.456944 |
| U.S. DEPARTMENT | 0.436495 |
| visit www.cdc.gov/mmwr | 0.437218 |
| fewer people | 0.439778 |
| CDC′s Behavioral Risk | 0.46984 |
| media campaigns | 0.43888 |
| lowest lung cancer | 0.55112 |
| strategies | 0.414057 |
| effective tobacco control | 0.478441 |
| Cigarette smoking | 0.451483 |
| new lung cancer | 0.583877 |
| lung cancer deaths | 0.558404 |
| greater investments | 0.439 |
| Mortality Weekly Report | 0.46622 |
| higher tobacco prices | 0.474623 |
| smoking patterns | 0.458754 |
| Thomas R. Frieden | 0.476088 |
| lung cancer incidence | 0.764894 |
|
CLICK HERE |
| 7522 |
Centers for Disease Control and Prevention |
Html |
en |
A Brief History of NCEH - 1980-1989 Highlights |
NCEH provides leadership to promote health & quality of life by preventing or controlling those diseases or disabilities resulting from interaction between people and the environment. Site has information/education resources on a broad range of topics, including asthma, birth defects, radiation, sanitation, lead in blood, and more. |
| Orange Validation Study | 0.767731 |
| public health practitioners | 0.73463 |
| exposure assessment | 0.72494 |
| unexplained deaths | 0.716212 |
| human exposure | 0.991117 |
| Environmental Health Services | 0.752894 |
| elevated serum levels | 0.71167 |
| adipose dioxin levels | 0.749915 |
| Agent Orange Validation | 0.739372 |
| Conducts health study | 0.747288 |
| DDT exposure | 0.735868 |
| results | 0.794217 |
| blood lead measurements | 0.721084 |
| lethal chemical weapons | 0.741635 |
| serum levels | 0.717801 |
| health studies | 0.713966 |
| Diabetic Retinopathy Study | 0.7155 |
| National Environmental Health | 0.931091 |
| Priority Toxicant Reference | 0.721789 |
| Health Impact Surveillance | 0.709738 |
| vietnam veterans | 0.839931 |
| lead exposure | 0.8264 |
| Environmental Health Conference | 0.928556 |
| California State Department | 0.746852 |
| Health Services | 0.755923 |
|
| Toxicant Reference Range | 0.724104 |
| similar dioxin levels | 0.744772 |
| blood cholesterol levels | 0.712932 |
| Studies human exposure | 0.789469 |
| Vietnam Experience Study | 0.778882 |
| Reference Range Study | 0.75032 |
| excessive blood levels | 0.726657 |
| adverse health effects | 0.709759 |
| background exposure | 0.722912 |
| International Clearinghouse study | 0.716349 |
| U.S. Vietnam veterans | 0.751157 |
| public health | 0.830316 |
| excessive exposure | 0.727659 |
| study results | 0.710998 |
| birth defects | 0.797819 |
| serum dioxin levels | 0.819416 |
| mercury exposure | 0.723705 |
| Chronic Disease Prevention | 0.724514 |
| injury control | 0.73569 |
| Public Health Service | 0.719061 |
| high exposure | 0.716227 |
| federal public health | 0.744331 |
| persistent health effects | 0.716315 |
| Agent Orange | 0.754308 |
|
CLICK HERE |
| 10530 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: July 29, 2013'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| CDC Director | 0.781835 |
| CDC | 0.925631 |
| Involving Inhalation Anthrax | 0.641746 |
| Public Health Matters | 0.6881 |
| free webinar | 0.662466 |
| respiratory illness | 0.632946 |
| Emergency Preparedness | 0.653685 |
| South Central Preparedness | 0.653218 |
| Respiratory Syndrome Coronavirus | 0.647202 |
| COCA Email Update | 0.666457 |
| FDA Safety Information | 0.658845 |
| Tom Frieden Twitter | 0.690314 |
| different health problems | 0.668298 |
| public health community | 0.693773 |
| HPV vaccination rates | 0.638483 |
| – (CDC) | 0.724776 |
| new avian influenza | 0.652948 |
| CDC Science Clips | 0.806899 |
| Additional COCA Conference | 0.651703 |
| CDC Influenza Division | 0.783088 |
| new H7N9 virus | 0.649176 |
| important safety information | 0.640064 |
| tribal public health | 0.690564 |
| racial/ethnic minority groups | 0.637067 |
|
| health care providers | 0.735512 |
| Dr. Tom Frieden | 0.680465 |
| Free CE credit/contact | 0.638592 |
| Weekly Flu View | 0.634728 |
| public health | 0.819639 |
| Specific Hazards preparedness | 0.648999 |
| EID Home Page | 0.636525 |
| Middle East Respiratory | 0.730698 |
| World Health Organization | 0.661521 |
| available immunization resources | 0.659453 |
| FDA Investigates Multistate | 0.648954 |
| public opinion polls | 0.655031 |
| live Twitter chat | 0.655339 |
| in-person training centers | 0.631369 |
| recent ACIP recommendations | 0.664952 |
| FoodSafety.gov Reports FDA | 0.653536 |
| recent vaccine recommendations | 0.646633 |
| interim travel advice | 0.637158 |
| Dr. Frieden | 0.66106 |
| East Respiratory Syndrome | 0.730675 |
| Emergency Response Learning | 0.647583 |
| Response Training Resources | 0.652339 |
| CDC subject matter | 0.812714 |
|
CLICK HERE |
| 11501 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | DBD Bulletin Fall 2013 | Publications |
Division of Bacterial Diseases Bulletin Fall |
| TaqMan Array Card | 0.258418 |
| Hicks LA | 0.257329 |
| vaccine effectiveness studies | 0.354663 |
| 13-valent pneumococcal conjugate | 0.792338 |
| infant pertussis | 0.209312 |
| United States | 0.400057 |
| BMC Infect Dis. | 0.300129 |
| pertactin-deficient Bordetella pertussis | 0.281318 |
| capsular serotype-specific loci | 0.27597 |
| immunocompromising conditions | 0.273233 |
| Pediatr Infect Dis | 0.388334 |
| 23-valent pneumococcal polysaccharide | 0.455092 |
| invasive pneumococcal disease | 0.403831 |
| MMWR Morb Mortal | 0.409206 |
| sickle cell disease | 0.256336 |
| Immunization Practices | 0.265574 |
| respiratory tract infections | 0.249723 |
| al H. Transcriptional | 0.295271 |
| upper respiratory tract | 0.412061 |
| CDC. Updated recommendations | 0.27041 |
| Mortal Wkly Rep. | 0.389349 |
| streptococcal disease | 0.204332 |
|
| confound detection | 0.202508 |
| pneumococcal conjugate vaccine | 0.959928 |
| Morb Mortal Wkly | 0.409162 |
| Pregnancy dose Tdap | 0.242532 |
| annual publications list | 0.240757 |
| human pharyngeal cells | 0.244405 |
| intrapartum antibiotic prophylaxis | 0.27515 |
| multiple pathogen detection | 0.259671 |
| acellular pertussis | 0.243116 |
| pertussis diagnostics | 0.210107 |
| pregnant women—Advisory Committee | 0.275203 |
| Pimenta FC | 0.201131 |
| Clin Infect Dis. | 0.302 |
| Advance Media Report | 0.235166 |
| meningococcal disease | 0.206247 |
| Infect Dis. | 0.3763 |
| Infect Dis J. | 0.388289 |
| Clin Vaccine Immunol. | 0.347921 |
| Hersh AL | 0.235582 |
| et al | 0.965794 |
| pneumococcal polysaccharide vaccine | 0.551068 |
| United States laboratories | 0.254275 |
|
CLICK HERE |
| 13673 |
Centers for Disease Control and Prevention |
Html |
en |
Fact Sheets - Trends in Tuberculosis 2014 - United States |
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination |
| infectious TB disease | 0.405584 |
| foreign-born persons | 0.369127 |
| state tb control | 0.547517 |
| United States | 0.71199 |
| TB Control Offices | 0.397167 |
| TB cases | 0.912781 |
| TB elimination | 0.341012 |
| latent tb infection | 0.660266 |
|
| MDR TB cases | 0.539177 |
| eligible TB patients | 0.41463 |
| tb disease | 0.520581 |
| culture-positive TB cases | 0.442558 |
| MDR TB | 0.557081 |
| TB incidence rate | 0.485281 |
| CDC. Latent TB | 0.395452 |
|
CLICK HERE |
| 13838 |
Centers for Disease Control and Prevention |
Html |
en |
Increasing Referrals to a YMCA-Based Diabetes PreventionProgram: Effects of Electronic Referral System Modification andProvider Education in Federally Qualified Health Centers |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| eligible patients | 0.508501 |
| segmented regression analysis | 0.377929 |
| Diabetes Educ | 0.256375 |
| health care provider | 0.23773 |
| Diabetes Prevention Programs | 0.380742 |
| YDPP referral process | 0.233238 |
| health centers | 0.231683 |
| New York City | 0.262821 |
| EHR lead-in period | 0.253954 |
| Program Research Group | 0.295552 |
| Disease Control | 0.233481 |
| referrals | 0.361912 |
| eligible patient referrals | 0.315834 |
| lead-in EHR period | 0.258653 |
| Montefiore Medical Center | 0.278042 |
| primary care referrals | 0.27427 |
| provider education intervention | 0.819742 |
| lifestyle modification program | 0.239847 |
| New York State | 0.42637 |
| diabetes prevention programming | 0.25308 |
| YDPP referral form | 0.233845 |
| patient referrals | 0.33881 |
| York State YDPP | 0.234195 |
| practice-based Diabetes Prevention | 0.250258 |
| staff education intervention | 0.251944 |
|
| education intervention shows | 0.270691 |
| community-based Diabetes Prevention | 0.2938 |
| electronic health record | 0.419172 |
| York State Health | 0.255289 |
| YMCA Diabetes Prevention | 0.378593 |
| medical directors | 0.236102 |
| diabetes prevention strategies | 0.278103 |
| lifestyle intervention | 0.247554 |
| YDPP program information | 0.233405 |
| clinic-based YDPP referrals | 0.277236 |
| Health Diabetes Prevention | 0.282288 |
| State Health Foundation | 0.242213 |
| State YMCA Diabetes | 0.2338 |
| new electronic referral | 0.242853 |
| Prevention Program Research | 0.31283 |
| New York | 0.717859 |
| federally qualified health | 0.317486 |
| York City Department | 0.246707 |
| Diabetes Prevention Program | 0.917319 |
| YDPP intervention | 0.2398 |
| electronic referral | 0.275254 |
| et al | 0.329226 |
| EHR lead-in | 0.33202 |
| Program lifestyle intervention | 0.242661 |
|
CLICK HERE |
| 15969 |
Centers for Disease Control and Prevention |
Html |
en |
Women and Men with possible Zika virus exposure Who Desire Pregnancy |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
|
| PregnancyError processing SSI | 0.770189 |
|
CLICK HERE |